

[ Tue, Nov 01st 2022
] - WOPRAI
[ Tue, Nov 01st 2022
] - WOPRAI
[ Tue, Nov 01st 2022
] - WOPRAI
[ Tue, Nov 01st 2022
] - WOPRAI
[ Tue, Nov 01st 2022
] - WOPRAI
[ Tue, Nov 01st 2022
] - WOPRAI
[ Tue, Nov 01st 2022
] - WOPRAI
[ Tue, Nov 01st 2022
] - WOPRAI
[ Tue, Nov 01st 2022
] - WOPRAI
[ Tue, Nov 01st 2022
] - WOPRAI
[ Tue, Nov 01st 2022
] - WOPRAI
[ Tue, Nov 01st 2022
] - WOPRAI
[ Tue, Nov 01st 2022
] - WOPRAI
[ Tue, Nov 01st 2022
] - WOPRAI
[ Tue, Nov 01st 2022
] - WOPRAI
[ Tue, Nov 01st 2022
] - WOPRAI
[ Tue, Nov 01st 2022
] - WOPRAI
[ Tue, Nov 01st 2022
] - WOPRAI
[ Tue, Nov 01st 2022
] - WOPRAI
[ Tue, Nov 01st 2022
] - WOPRAI
[ Tue, Nov 01st 2022
] - WOPRAI
[ Tue, Nov 01st 2022
] - WOPRAI
[ Tue, Nov 01st 2022
] - WOPRAI
[ Tue, Nov 01st 2022
] - WOPRAI
[ Tue, Nov 01st 2022
] - WOPRAI
[ Tue, Nov 01st 2022
] - WOPRAI
[ Tue, Nov 01st 2022
] - WOPRAI
[ Tue, Nov 01st 2022
] - WOPRAI
Esther Hong Initiated (ACAD) at Hold and Held Target at $17 on, Nov 1st, 2022
Esther Hong of Loop Capital, Initiated "ACADIA Pharmaceuticals Inc." (ACAD) at Hold and Held Target at $17 on, Nov 1st, 2022.
Esther has made no other calls on ACAD in the last 4 months.
There are 8 other peers that have a rating on ACAD. Out of the 8 peers that are also analyzing ACAD, 4 agree with Esther's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Salveen Richter of "Goldman Sachs" Maintained at Hold with Decreased Target to $15 on, Wednesday, August 10th, 2022
- Vamil Divan of "Mizuho" Maintained at Hold with Decreased Target to $19 on, Wednesday, August 10th, 2022
- Jeffrey Hung of "Morgan Stanley" Maintained at Hold with Decreased Target to $18 on, Tuesday, August 9th, 2022
- Neena Bitritto-Garg of "Citigroup" Downgraded from Strong Buy to Hold and Decreased Target to $15 on, Monday, August 8th, 2022
These are the ratings of the 4 analyists that currently disagree with Esther
- Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $25 on, Tuesday, August 9th, 2022
- Gregory Renza of "RBC Capital" Maintained at Buy with Decreased Target to $21 on, Tuesday, August 9th, 2022
- Marc Goodman of "SVB Leerink" Maintained at Buy with Decreased Target to $21 on, Tuesday, August 9th, 2022
- Ritu Baral of "Cowen & Co." Maintained at Buy with Decreased Target to $21 on, Monday, August 8th, 2022
Contributing Sources